Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is […]
Source
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in […]
Source
This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country […]
Source
Which pharmaceutical companies have the most drug patents in South Africa? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It […]
Source
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection […]
Source
Pharmaceutical companies with the most orphan drugs Read Post »
Annual Drug Patent Expirations for ABILIFY+ASIMTUFII Abilify Asimtufii is a drug marketed by Otsuka and is included in one NDA. […]
Source
Annual Drug Patent Expirations for XPHOZAH Xphozah is a drug marketed by Ardelyx Inc and is included in one NDA. […]
Source
Annual Drug Patent Expirations for ZOKINVY Zokinvy is a drug marketed by Eiger Biopharms and is included in one NDA. […]
Source
New patent expiration for Eiger Biopharms drug ZOKINVY Read Post »